{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:47:45Z","timestamp":1787168865758,"version":"build-2736575974"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"11-12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Human papillomavirus (HPV) is the most common sexually transmitted infection (STI) in the U.S. military and accounts for more healthcare visits than the next two most common STIs combined. Human papillomavirus is preventable with a safe, effective, prophylactic vaccine that has been available since 2006, yet vaccination rates remain low. The vaccine is approved for females and males aged 9-45\u2009years for prevention of HPV-related dysplasia and cancers. Although it is recommended by the Centers for Disease Control and Prevention (CDC)\u2019s Advisory Committee on Immunization Practices (ACIP), it is not part of the U.S. military\u2019s mandatory vaccine list. Human papillomavirus does not just affect female service members\u2014male service members have a higher reported seropositive rate than their civilian counterparts and can develop oropharyngeal, anal, or penile cancers as sequelae of HPV. Oropharyngeal cancer, more common in males, is the fastest growing and most prevalent HPV-related cancer in the USA. Several countries, such as Australia and Sweden, have successfully implemented mandatory vaccine programs and have seen rates of HPV-related diseases, including cancer, decline significantly. Some models project that cervical cancer, which is the fifth-most common cancer in active duty women, will be eliminated in the next 20\u2009years as a result of mandatory vaccination programs. Between higher seropositive rates and lack of widespread vaccination, HPV dysplasia and cancer result in lost work time, decreased force readiness, negative monetary implications, and even separation from service. With more than half of the 1.3 million service members in the catch-up vaccination age range of less than 26\u2009years of age, we are poised to have a profound impact through mandatory active duty service member vaccination. Although multiple strategies for improving vaccination rates have been proposed, mandatory vaccination would be in line with current joint service policy that requires all ACIP-recommended vaccines. It is time to update the joint service guidelines and add HPV vaccine to the list of mandatory vaccines.<\/jats:p>","DOI":"10.1093\/milmed\/usab232","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T01:08:06Z","timestamp":1623460086000},"page":"305-308","source":"Crossref","is-referenced-by-count":13,"title":["Mandatory HPV Vaccination; Opportunity to Save Lives, Improve Readiness and Cut Costs"],"prefix":"10.1093","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5528-2525","authenticated-orcid":false,"given":"Collin A","family":"Sitler","sequence":"first","affiliation":[{"name":"Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa F","family":"Weir","sequence":"additional","affiliation":[{"name":"Air Force Medical Readiness Agency, Falls Church, VA 22042, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin A","family":"Keyser","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Brooke Army Medical Center, Joint Base San Antonio, TX 78234, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yovanni","family":"Casablanca","sequence":"additional","affiliation":[{"name":"Gynecologic Cancer Center of Excellence, Department of Gynecologic Surgery and Obstetrics, Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Hope","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Brooke Army Medical Center, Joint Base San Antonio, TX 78234, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,12]]},"reference":[{"issue":"3","key":"2021110307362270400_R1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/OLQ.0b013e318286bb53","article-title":"Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008","volume":"40","author":"Satterwhite","year":"2013","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2021110307362270400_R2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/1055-9965.EPI-18-0885","article-title":"Trends in human papillomavirus vaccine types 16 and 18 in cervical precancers, 2008\u20132014","volume":"28","author":"McClung","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"37","key":"2021110307362270400_R3","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1016\/j.vaccine.2020.06.073","article-title":"Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy","volume":"38","author":"Bukowinski","year":"2020","journal-title":"Vaccine"},{"issue":"12","key":"2021110307362270400_R4","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1002\/cncr.30588","article-title":"Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases","volume":"123","author":"Berman","year":"2017","journal-title":"Cancer"},{"issue":"9","key":"2021110307362270400_R5","first-page":"9","article-title":"Human papillomavirus vaccine initiation, coverage, and completion rates among U.S. active component service members, 2007\u20132017","volume":"25","author":"Clark","year":"2018","journal-title":"MSMR"},{"issue":"1","key":"2021110307362270400_R6","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S2468-2667(18)30183-X","article-title":"The projected timeframe until cervical cancer elimination in Australia: a modelling study","volume":"4","author":"Hall","year":"2019","journal-title":"Lancet Public Health"},{"issue":"8194","key":"2021110307362270400_R7","article-title":"Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study","volume":"365","author":"Palmer","year":"2019","journal-title":"BMJ"},{"issue":"14","key":"2021110307362270400_R8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"7\u20138","key":"2021110307362270400_R9","doi-asserted-by":"crossref","first-page":"e1155","DOI":"10.1093\/milmed\/usaa024","article-title":"Human papilloma virus vaccination compliance in a military aviation training community","volume":"185","author":"Porter","year":"2020","journal-title":"Mil Med"},{"issue":"10","key":"2021110307362270400_R10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.7205\/MILMED-D-15-00477","article-title":"Improving human papillomavirus vaccinations in military women","volume":"181","author":"Wedel","year":"2016","journal-title":"Mil Med"},{"issue":"1","key":"2021110307362270400_R11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1188\/18.CJON.104-107","article-title":"Vaccination for human papillomavirus: immunization practices in the U.S. Military","volume":"22","author":"Buechel","year":"2018","journal-title":"Clin J Oncol Nurs"},{"issue":"7","key":"2021110307362270400_R12","first-page":"23","article-title":"Incident diagnoses of cancers in the active component and cancer-related deaths in the active and reserve components, U.S. Armed Forces, 2005\u20132014","volume":"23","author":"Lee","year":"2016","journal-title":"MSMR"},{"issue":"7\u20138","key":"2021110307362270400_R13","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1080\/21645515.2019.1603562","article-title":"Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States","volume":"15","author":"Chesson","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"2021110307362270400_R14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s10900-017-0447-z","article-title":"Prevalence of human papillomavirus genotypes and abnormal pap smears among women in the military health system","volume":"43","author":"Daly","year":"2018","journal-title":"J Community Health"},{"issue":"3","key":"2021110307362270400_R15","first-page":"13","article-title":"Armed Forces Health Surveillance Branch: Update: sexually transmitted infections, active component, U.S. Armed Forces, 2012\u20132020","volume":"28","year":"2021","journal-title":"MSMR"},{"issue":"4","key":"2021110307362270400_R16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/186\/11-12\/305\/41067498\/usab232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/milmed\/article-pdf\/186\/11-12\/305\/41067498\/usab232.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T03:38:17Z","timestamp":1635910697000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/186\/11-12\/305\/6297059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,12]]},"references-count":16,"journal-issue":{"issue":"11-12","published-online":{"date-parts":[[2021,6,12]]},"published-print":{"date-parts":[[2021,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usab232","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,11,1]]},"published":{"date-parts":[[2021,6,12]]}}}